D.E. Shaw & Co’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.7M | Buy |
544,421
+74,136
| +16% | +$6.57M | 0.03% | 652 |
|
|
2025
Q4 | $37.8M | Buy |
470,285
+315,947
| +205% | +$26.5M | 0.02% | 861 |
|
|
2025
Q3 | $15.1M | Buy |
154,338
+76,085
| +97% | +$6.13M | 0.01% | 1380 |
|
|
2025
Q2 | $5.45M | Buy |
78,253
+71,943
| +1,140% | +$4.1M | ﹤0.01% | 1970 |
|
|
2025
Q1 | $313K | Sell |
6,310
-34,070
| -84% | -$2.15M | ﹤0.01% | 3744 |
|
|
2024
Q4 | $2.82M | Buy |
40,380
+25,520
| +172% | +$2.12M | ﹤0.01% | 2455 |
|
|
2024
Q3 | $1.56M | Sell |
14,860
-3,183
| -18% | -$372K | ﹤0.01% | 2907 |
|
|
2024
Q2 | $2.57M | Sell |
18,043
-4,073
| -18% | -$470K | ﹤0.01% | 2426 |
|
|
2024
Q1 | $2.47M | Sell |
22,116
-53,116
| -71% | -$6.33M | ﹤0.01% | 2464 |
|
|
2023
Q4 | $9.76M | Sell |
75,232
-34,471
| -31% | -$4.75M | 0.01% | 1384 |
|
|
2023
Q3 | $17.9M | Buy |
109,703
+41,193
| +60% | +$7.25M | 0.02% | 929 |
|
|
2023
Q2 | $12.6M | Buy |
68,510
+18,221
| +36% | +$2.62M | 0.01% | 1157 |
|
|
2023
Q1 | $6.7M | Buy |
50,289
+35,689
| +244% | +$4.19M | 0.01% | 1699 |
|
|
2022
Q4 | $1.16M | Sell |
14,600
-4,184
| -22% | -$295K | ﹤0.01% | 3334 |
|
|
2022
Q3 | $1.14M | Buy |
18,784
+7,590
| +68% | +$490K | ﹤0.01% | 3499 |
|
|
2022
Q2 | $614K | Sell |
11,194
-2,720
| -20% | -$158K | ﹤0.01% | 3977 |
|
|
2022
Q1 | $1.05M | Buy |
+13,914
| New | +$950K | ﹤0.01% | 3880 |
|
|
2021
Q4 | – | Sell |
-8,706
| Closed | -$409K | – | 5344 |
|
|
2021
Q3 | $409K | Buy |
+8,706
| New | +$379K | ﹤0.01% | 4197 |
|
|
2020
Q1 | – | Sell |
-45,626
| Closed | -$1.1M | – | 3877 |
|
|
2019
Q4 | $1.1M | Sell |
45,626
-102,395
| -69% | -$2.16M | ﹤0.01% | 2912 |
|
|
2019
Q3 | $2.53M | Buy |
148,021
+21,082
| +17% | +$337K | ﹤0.01% | 2184 |
|
|
2019
Q2 | $1.91M | Buy |
126,939
+95,487
| +304% | +$1.71M | ﹤0.01% | 2273 |
|
|
2019
Q1 | $633K | Buy |
+31,452
| New | +$639K | ﹤0.01% | 2877 |
|
|
2017
Q4 | – | Sell |
-105,954
| Closed | -$2.9M | – | 3550 |
|
|
2017
Q3 | $2.9M | Sell |
105,954
-24,717
| -19% | -$547K | ﹤0.01% | 1766 |
|
|
2017
Q2 | $2.74M | Buy |
130,671
+80,638
| +161% | +$1.7M | ﹤0.01% | 1775 |
|
|
2017
Q1 | $941K | Sell |
50,033
-41,547
| -45% | -$654K | ﹤0.01% | 2332 |
|
|
2016
Q4 | $1.33M | Sell |
91,580
-37,012
| -29% | -$504K | ﹤0.01% | 2287 |
|
|
2016
Q3 | $1.71M | Buy |
128,592
+11,056
| +9% | +$128K | ﹤0.01% | 2036 |
|
|
2016
Q2 | $1.26M | Buy |
117,536
+30,075
| +34% | +$323K | ﹤0.01% | 2261 |
|
|
2016
Q1 | $979K | Buy |
87,461
+41,986
| +92% | +$429K | ﹤0.01% | 2368 |
|
|
2015
Q4 | $471K | Sell |
45,475
-16,086
| -26% | -$171K | ﹤0.01% | 3126 |
|
|
2015
Q3 | $658K | Buy |
61,561
+7,093
| +13% | +$86.4K | ﹤0.01% | 2884 |
|
|
2015
Q2 | $644K | Buy |
54,468
+28,867
| +113% | +$334K | ﹤0.01% | 3012 |
|
|
2015
Q1 | $244K | Buy |
25,601
+17,201
| +205% | +$178K | ﹤0.01% | 3378 |
|
|
2014
Q4 | $86K | Sell |
8,400
-913
| -10% | -$7.92K | ﹤0.01% | 3915 |
|
|
2014
Q3 | $74K | Buy |
9,313
+3,856
| +71% | +$29K | ﹤0.01% | 4005 |
|
|
2014
Q2 | $44K | Sell |
5,457
-1,735
| -24% | -$12.9K | ﹤0.01% | 4110 |
|
|
2014
Q1 | $62K | Sell |
7,192
-16,538
| -70% | -$152K | ﹤0.01% | 4196 |
|
|
2013
Q4 | $232K | Sell |
23,730
-11
| -0% | -$100 | ﹤0.01% | 4197 |
|
|
2013
Q3 | $200K | Buy |
23,741
+4,065
| +21% | +$32.9K | ﹤0.01% | 4091 |
|
|
2013
Q2 | $143K | Buy |
+19,676
| New | +$114K | ﹤0.01% | 3824 |
|
Other funds holding ACLS
VPM
RP
VCM
D.E. Shaw & Co's ACLS Position: Q1 2026 in Review
D.E. Shaw & Co increased its Axcelis (ACLS) stake by 16% in Q1 2026, buying an estimated $6.57M and bringing the position to 544,421 shares worth $50.7M. The position accounts for 0.03% of the portfolio, ranked #652.
D.E. Shaw & Co first reported a position in ACLS in Q2 2013 and has held it in 40 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- D.E. Shaw & Co held 544,421 shares of Axcelis worth $50.7M as of Q1 2026.
- D.E. Shaw & Co bought 74,136 Axcelis shares in Q1 2026, an estimated $6.57M.
- Axcelis made up 0.03% of D.E. Shaw & Co's portfolio in Q1 2026, its #652 holding.
- D.E. Shaw & Co first reported a position in Axcelis in Q2 2013 and has held it in 40 quarters since.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.